Replies to post #1833 on Iterum Therapeutics (ITRM)

[exwannabe]

At least they have plenty of cash on the books to fund this for quite some time. No reason to drop 40% off what is likely a 6 month delay. If you have the time you simply buy more if you paid more than current price to cost avg down. Nothing has changed in terms of the market or efficacy. The FDA just being thorough as they should. I’ll take this approval in December and see you at $4.

I think it is a good buy now, so no real argument there. But you need a reality check on the timelines.

They are talking another P3 trial. 2 years would be warp speed (even with the advantage of effective hindsight).